Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial (Q35747036)
Jump to navigation
Jump to search
scientific article published on February 3, 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial |
scientific article published on February 3, 2012 |
Statements
1 reference
Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial (English)
1 reference
Edward Kerwin
1 reference
Barbara Knorr
1 reference
Tulin Shekar
1 reference
Sibabrata Banerjee
1 reference
Heribert Staudinger
1 reference
Donald P. Tashkin
Dennis E. Doherty
Carlos E. Matiz-Bueno
3 February 2012
1 reference
7
1 reference
43-55
1 reference
1 February 2012
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference